Jasper Therapeutics, Inc. (JSPR)
JSPR Stock Price Chart
Explore Jasper Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze JSPR price movements and trends.
JSPR Company Profile
Discover essential business fundamentals and corporate details for Jasper Therapeutics, Inc. (JSPR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Jan 2020
Employees
64.00
Website
https://jaspertherapeutics.comCEO
Ronald A. Martell
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Financial Timeline
Browse a chronological timeline of Jasper Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$1.01.
Earnings released on 13 Aug 2025
EPS came in at -$1.74 falling short of the estimated -$1.20 by -45.00%.
Earnings released on 12 May 2025
EPS came in at -$1.41 falling short of the estimated -$1.17 by -20.51%.
Earnings released on 27 Feb 2025
EPS came in at -$1.62 falling short of the estimated -$1.27 by -27.56%, while revenue for the quarter reached $1.17M .
Earnings released on 7 Nov 2024
EPS came in at -$1.24 falling short of the estimated -$1.09 by -13.76%.
Earnings released on 13 Aug 2024
EPS came in at -$0.97 surpassing the estimated -$1.09 by +11.01%.
Earnings released on 14 May 2024
EPS came in at -$1.03 surpassing the estimated -$1.26 by +18.25%.
Earnings released on 4 Mar 2024
EPS came in at -$1.50 surpassing the estimated -$1.65 by +9.09%, while revenue for the quarter reached $2.05M .
Stock split effective on 4 Jan 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2023
EPS came in at -$1.60 falling short of the estimated -$1.50 by -6.67%.
Earnings released on 11 Aug 2023
EPS came in at -$1.50 falling short of the estimated -$1.30 by -15.38%.
Earnings released on 12 May 2023
EPS came in at -$1.60 falling short of the estimated -$1.50 by -6.67%.
Earnings released on 8 Mar 2023
EPS came in at -$3.60 surpassing the estimated -$3.70 by +2.70%.
Earnings released on 10 Nov 2022
EPS came in at -$3.20 surpassing the estimated -$3.50 by +8.57%.
Earnings released on 12 Aug 2022
EPS came in at -$2.90 matching the estimated -$2.90.
Earnings released on 12 May 2022
EPS came in at -$3.50 surpassing the estimated -$3.60 by +2.78%.
Earnings released on 18 Mar 2022
EPS came in at -$0.79 falling short of the estimated -$0.34 by -132.35%.
Earnings released on 12 Nov 2021
EPS came in at -$0.69 falling short of the estimated -$0.28 by -146.43%.
Earnings released on 16 Aug 2021
EPS came in at -$0.84 .
Earnings released on 24 May 2021
EPS came in at -$0.26 .
Earnings released on 30 Mar 2021
EPS came in at -$0.26 .
Earnings released on 10 Nov 2020
EPS came in at -$1.08 .
JSPR Stock Performance
Access detailed JSPR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.